Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Wayne Foster Insider Profile
4 Followers
Wayne Foster, VP Finance at Mersana Therapeutics, holds 50.13K shares in Atea Pharmaceuticals (Ticker: AVIR), holds 71.08K shares in Mersana Therapeutics (Ticker: MRSN).
Wayne Foster has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Wayne Foster holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Wayne Foster
Wayne Foster's Trading History
Mersana Therapeutics
Feb 01, 2018
VP Finance
Uninformative Buy
44.58K
$37.89K
Atea Pharmaceuticals
Feb 04, 2025
EVP, Chief Accounting Officer
Uninformative Buy
89.57K
$154.90K
List of latest transactions for each holding click on a transaction to see Wayne Foster's performance on stock
You May Also Like
Wayne Foster insider profile FAQ
What is the percentage of profitable transactions made by Wayne Foster?
The percentage of profitable transactions made by Wayne Foster is ―.
What is the average return per transaction made by Wayne Foster?
The average return per transaction made by Wayne Foster is ―.
What stocks does Wayne Foster hold?
Wayne Foster holds: MRSN, AVIR stocks.
What was Wayne Foster’s latest transaction?
Wayne Foster latest transaction was an Uninformative Buy of $89.57K.
What was Wayne Foster's most profitable transaction?
Wayne Foster’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Wayne Foster's role in Mersana Therapeutics?
Wayne Foster's role in Mersana Therapeutics is VP Finance.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.